RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327,930 | +24.8% | 109,310 | +45.2% | 0.00% | +50.0% |
| Q4 2022 | $262,797 | -95.3% | 75,300 | -50.0% | 0.00% | -95.7% |
| Q3 2022 | $5,572,000 | +351.2% | 150,500 | +174.6% | 0.05% | +327.3% |
| Q4 2021 | $1,235,000 | -58.3% | 54,800 | -51.5% | 0.01% | -64.5% |
| Q3 2021 | $2,961,000 | +60.2% | 112,938 | +95.5% | 0.03% | +55.0% |
| Q2 2021 | $1,848,000 | -3.6% | 57,761 | +6.0% | 0.02% | -13.0% |
| Q1 2021 | $1,918,000 | – | 54,501 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 853,206 | $30,041,000 | 3.26% |
| COMMODORE CAPITAL LP | 161,565 | $5,689,000 | 2.27% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $7,042,000 | 1.98% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 451,412 | $15,894,000 | 1.30% |
| Avoro Capital Advisors LLC | 1,525,000 | $53,695,000 | 0.93% |
| RTW INVESTMENTS, LP | 1,530,717 | $53,897,000 | 0.84% |
| Pegasus Asset Management, Inc. | 26,958 | $949,000 | 0.48% |
| COWEN AND COMPANY, LLC | 166,942 | $5,878,000 | 0.40% |
| Ikarian Capital, LLC | 290,207 | $10,218,000 | 0.34% |
| Spotlight Asset Group, Inc. | 24,565 | $865,000 | 0.32% |